Retrospective study evaluates MRI changes in PI-RADS lesions after prostate artery embolization, suggesting stable or reduced scores.
Objectives To evaluate changes in PI-RADS ≥ 3 lesions on prostate MRI after prostate artery embolization (PAE) performed for lower urinary tract symptoms. Methods This retrospective single-center study included 18 consecutive patients, each presenting with 1 PI-RADS ≥ 3 prostatic images on pre-PAE MRI and who underwent follow-up MRI after PAE. We assessed changes in PI-RADS score, infarcted areas, and prostate volume. Results Before PAE, all 18 lesions (mean PSA density : 0,078) were either biopsy-negative (n = 4) or deemed not requiring biopsy based on multidisciplinary consensus (n = 12), except for 1 case of non-clinically significant prostate cancer identified before PAE and 1 patient with a PIRADS 4 lesion who declined biopsy. The mean delay to post-PAE MRI was 120 days. After PAE, no new PI-RADS ≥ 3 lesions appeared, and no lesion was upgraded. Both initially classified as PI-RADS 5 lesions (negative on biopsies) were downgraded to PI-RADS 1. Among the 6 PI-RADS 4 lesions, 3 remained stable, 2 were downgraded to PI-RADS 3 and 1 to PI-RADS 2. Of the 10 PI-RADS 3 lesions, 8 achieved PI-RADS 1 status and 2 remained stable. Conclusions Following PAE, pre-existing PI-RADS ≥ 3 lesions demonstrate stability or reduction in PI-RADS on MRI. However, radiopathological correlation studies are warranted to estimate the diagnostic reliability of the PI-RADS score in the post-PAE settings Advances in knowledge This study shows that PI-RADS ≥ 3 images are downgraded after PAE. It doesn’t imply that potential prostate cancer can be cured by PAE.
No takes yet. Share an insight, caveat, or question.
Croci et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: